Given its role in cancer metabolism, ChoK represents a promising therapeutic target. Several strategies are being explored: 1. Small Molecule Inhibitors: Compounds that specifically inhibit ChoK activity have shown anti-cancer effects in preclinical models. 2. RNA Interference (RNAi): Silencing ChoK gene expression using siRNA or shRNA can reduce tumor growth. 3. Combination Therapies: Targeting ChoK in conjunction with other therapies, such as chemotherapy or radiotherapy, may enhance treatment efficacy.
